Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.44 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.42 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.40 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.40 |
| ▸ | QPCT | Q16769 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4581654 | 0.82 | FDPS (0.47) | FDPSCYP19A1TBXAS1CYP11B1CYP11B2 | |
| SCHEMBL20953982 | 0.82 | FDPS (0.47) | FDPSCYP19A1TBXAS1CYP11B1CYP11B2 | |
| Iodide SCHEMBL4367921 | 0.80 | FDPS (0.46) | FDPSCYP19A1TBXAS1CYP11B1CYP11B2 | |
| SCHEMBL4681300 | 0.80 | FDPS (0.50) | FDPSTBXAS1 | |
| SCHEMBL4681306 | 0.80 | FDPS (0.50) | FDPSCYP19A1TBXAS1CYP11B1CYP11B2 | |
| SCHEMBL14738593 | 0.79 | — | — | |
| SCHEMBL1369052 | 0.79 | — | — | |
| SCHEMBL171211 | 0.79 | — | — | |
| SCHEMBL17484070 | 0.78 | TBXAS1 (0.47) | FDPSCYP19A1TBXAS1CYP11B1CYP11B2 | |
| Bromide SCHEMBL18191796 | 0.78 | FDPS (0.47) | FDPSCYP19A1TBXAS1CYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113046751-A | Conductive metal vapor phase corrosion inhibitor and application thereof | 浙江工业大学 | 2021-06-29 | — | — | CN | claimed |
| WO-2025215201-A1 | PANNEXIN-1 INHIBITORS AND USES THEREOF | PANNTHERAPI (FR) | 2025-10-16 | — | — | WO | disclosed |
| CN-116217889-A | High-strength and high-toughness self-repairing supermolecular polyurethane elastomer based on thiolactone chemistry and preparation method thereof | 西北工业大学 | 2023-06-06 | — | — | CN | disclosed |
| CN-108456179-B | Compound TVA-X with neuroprotective effect and preparation method and application thereof | 雷鹏程 | 2021-09-28 | — | — | CN | disclosed |
| CN-113046751-A | Conductive metal vapor phase corrosion inhibitor and application thereof | 浙江工业大学 | 2021-06-29 | — | — | CN | disclosed |
| US-20150126679-A1 | POLYMERIZABLE BENZOXAZINE COMPOUNDS WITH INTERFACIAL ACTIVE OR SURFACE ACTIVE PROPERTIES | HENKEL AG & CO KGAA (DE) | 2015-05-07 | — | — | US | disclosed |
| US-20150126669-A1 | POLYMERIZABLE BENZOXAZINE COMPOUNDS WITH INTERFACIAL ACTIVE OR SURFACE ACTIVE PROPERTIES | HENKEL AG & CO KGAA (DE) | 2015-05-07 | — | — | US | disclosed |
| EP-2430073-B1 | CATIONIC BENZOXAZINE (CO)POLYMERS | HENKEL AG & CO KGAA (DE) | 2015-01-07 | — | — | EP | disclosed |
| EP-2430137-B1 | COLOR-PROTECTING WASHING OR CLEANING AGENT | HENKEL AG & CO KGAA (DE) | 2014-11-12 | — | — | EP | disclosed |
| US-8580726-B2 | Color-protecting washing or cleaning agent | HENKEL AG & CO. KGAA (DE) | 2013-11-12 | — | — | US | disclosed |
| EP-0293500-A1 | 3-heteroalkyl-2,4.quinzaoline-diones | AMERICAN CYANAMID COMPANY (US) | 1988-12-07 | — | — | EP | disclosed |
| US-4753944-A | INHIBITING THROMBOXANE SYNTHETASE | AMERICAN CYANAMID COMPANY (US) | 1988-06-28 | — | — | US | disclosed |
| US-4728663-A | HYPOTENSIVE, ANTIARRHYTHMIA | AMERICAN CYANAMID COMPANY (US) | 1988-03-01 | — | — | US | disclosed |
| US-4710502-A | THROMBOXANE SYNTHETASE INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1987-12-01 | — | — | US | disclosed |
| US-4684654-A | THROMBOXANE SYNTHETASE INHIBITORS, HYPOTENSIVES | AMERICAN CYANAMID COMPANY (US) | 1987-08-04 | — | — | US | disclosed |
| EP-0230035-A2 | Omega-[(hetero)alkyl]benz[cd]indol-2-amines | AMERICAN CYANAMID COMPANY (US) | 1987-07-29 | — | — | EP | disclosed |
| US-4680293-A | 3-imidazolylalkyl-, triazolylalkyl-, pyridinylalkyl-1,2,3-benzotriazin-4(3H)-ones and derivatives thereof | AMERICAN CYANAMID COMPANY (US) | 1987-07-14 | — | — | US | disclosed |
| US-4568687-A | THROMBOXANE SYNTHETASE TNZYME INHIBITORS; HYPOTENSIVE AGENTS, CARDIOTONIC AGENTS | AMERICAN CYANAMID COMPANY (US) | 1986-02-04 | — | — | US | disclosed |
| US-4555519-A | Thromboxane synthetase enzyme inhibiting N-[(1H-imidazol-1-yl) and (1H-1,2,4-triazol-1-yl)alkyl]pyridinecarboxamides | AMERICAN CYANAMID COMPANY (US) | 1985-11-26 | — | — | US | disclosed |
| EP-0117462-A2 | N-(2-4-(1H-imidazol-1-yl)alkyl)arylamides | AMERICAN CYANAMID COMPANY (US) | 1984-09-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150126679-A1 | POLYMERIZABLE BENZOXAZINE COMPOUNDS WITH INTERFACIAL ACTIVE OR SURFACE ACTIVE PROPERTIES | CYP4Z1, PRDX4, PRDX1 | FDPS 1566/4885CYP19A1 291/4885TBXAS1 34/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.